BIOSPHERE MEDICAL INC
S-8, EX-5.1, 2000-11-16
PHARMACEUTICAL PREPARATIONS
Previous: BIOSPHERE MEDICAL INC, S-8, 2000-11-16
Next: BIOSPHERE MEDICAL INC, S-8, EX-23.2, 2000-11-16




<PAGE>

                                                                     EXHIBIT 5.1
                                HALE AND DORR LLP
                               Counsellors At Law
                  60 State Street, Boston, Massachusetts 02109
                       TEL 617-526-6000 * FAX 617-526-5000

                                November 16, 2000

BioSphere Medical, Inc.
1050 Hingham Street
Rockland, Massachusetts 02370

         Re: 1997 STOCK INCENTIVE PLAN

Ladies and Gentlemen:

         We have assisted in the preparation of a Registration Statement on Form
S-8 (the "Registration Statement") to be filed with the Securities and Exchange
Commission (the "Commission") under the Securities Act of 1933, as amended (the
"Securities Act"), relating to 1,850,000 shares of Common Stock, $0.01 par value
per share (the "Shares"), of BioSphere Medical, Inc., a Delaware corporation
(the "Company"), issuable under the Company's 1997 Stock Incentive Plan (the
"Plan").

         We have examined the Certificate of Incorporation, as amended, and
By-Laws of the Company, and originals, or copies certified to our satisfaction,
of all pertinent records of the meetings of the directors and stockholders of
the Company, the Registration Statement and such other documents relating to the
Company as we have deemed material for the purposes of this opinion.

         In our examination of the foregoing documents, we have assumed the
genuineness of all signatures, the authenticity of all documents submitted to us
as originals, the conformity to original documents of all documents submitted to
us as certified, photostatic or other copies, the authenticity of the originals
of such latter documents and the legal competence of all signatories to such
documents.

         We assume that the appropriate action will be taken, prior to the offer
and sale of the Shares in accordance with the Plan, to register and qualify the
Shares for sale under all applicable state securities or "blue sky" laws.

         We express no opinion herein as to the laws of any state or
jurisdiction other than the state laws of The Commonwealth of Massachusetts, the
General Corporation Law of the State of Delaware and the federal laws of the
United States of America.

<PAGE>

BioSphere Medical, Inc.
November 16, 2000
Page 2

         Based upon and subject to the foregoing, we are of the opinion that the
Shares have been duly authorized for issuance and, when the Shares are issued
and paid for in accordance with the terms and conditions of the Plan, the Shares
will be validly issued, fully paid and nonassessable.

         It is understood that this opinion is to be used only in connection
with the offer and sale of the Shares while the Registration Statement is in
effect.

         Please note that we are opining only as to the matters expressly set
forth herein, and no opinion should be inferred as to any other matters.

         We hereby consent to the filing of this opinion with the Commission as
an exhibit to the Registration Statement in accordance with the requirements of
Item 601(b)(5) of Regulation S-K under the Securities Act. In giving such
consent, we do not hereby admit that we are in the category of persons whose
consent is required under Section 7 of the Securities Act or the rules and
regulations of the Commission.

                                Very truly yours,

                                /s/ HALE AND DORR LLP

                                HALE AND DORR LLP



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission